What The Study Did: In this secondary analysis of a randomized clinical trial, researchers examined the association of age with the benefit of intensive treatment to lower lipid levels with a combination therapy of simvastatin and ezetimibe compared to treatment with simvastatin alone after acute coronary syndrome in older patients.
Authors: Richard G. Bach, M.D., of Washington University School of Medicine in St. Louis, is the corresponding author.
(doi:10.1001/jamacardio.2019.2306)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
###
Media advisory: The full study, commentary and podcast are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time: https://jamanetwork.com/journals/jamacardiology/fullarticle/2738104?guestAccessKey=b98d7a70-e094-48e9-ad30-afe6fa5bbc3d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071719
JAMA Cardiology